![]() |
市场调查报告书
商品编码
1374833
全球气管切开插管市场 - 2023-2030Global Tracheostomy Tube Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
气管造口术是一种外科手术,涉及在颈部切开一个切口,将一根管子插入气管,即所谓的气管造口管。气管造口管是一种人工气道,透过手术透过喉咙的开口直接放入气管。它绕过上呼吸道作为建立呼吸连结的手段。气管切开插管有利于正压通气,允许清除分泌物,并为上呼吸道阻塞的患者提供通畅的气道。
当通常的呼吸路线因某种原因被阻塞或减少时,气管造口术提供了一条有助于呼吸的空气通道。当健康问题需要长期使用机器(呼吸器)来帮助呼吸时,通常需要气管切开插管。在极少数情况下,当气道突然阻塞时,例如脸部或颈部外伤后,会进行紧急气管切开术。当不再需要气管切开术时,可以使其癒合闭合或透过手术闭合。对某些人来说,气管切开术是永久性的。
气管切开插管的不断进步预计将在预测期内推动市场发展。这些管子的进步有助于为患者提供多种选择,让患者根据自己的选择进行选择。先进的气管切开插管的设计通常优先考虑患者的舒适度。更柔软的材料、减少刺激和符合人体工学的设计等特点有助于提高患者的耐受性和依从性,从而提高气管造口插管的接受度。
例如,2020 年 1 月,全球医疗器材製造商 Smiths Medical 在其气管切开插管系列中推出了新的聚氯乙烯 (PVC) 气管切开插管产品组合。在照顾气管造口患者时,应选择最适合患者特定临床需求的插管。新型气管切开插管为各种患者提供了多种选择。
此外,技术创新旨在解决与气管造口管相关的常见併发症,例如感染、肉芽肿形成和气管狭窄。透过最大限度地减少这些风险,先进的气管切开插管提高了手术的安全性,鼓励患者在需要时选择这种干预措施。气喘等气道疾病的增加增加了对气管切开插管的需求。
例如,根据 CDC 的 2020 年全国健康访问调查 (NHIS),估计美国有 2,520 万成年人,其中包括 420 万名儿童患有气喘。 2020 年,超过 1,030 万名气喘患者(包括约 180 万名儿童)报告曾出现过一次或多次气喘发作。因此,对于出现急性呼吸窘迫的气喘患者,首选经口气管插管。因此,从上述表述来看,市场预期将带动市场成长。
此外,材料和设计的进步导致气管切开插管的功能得到改善。这包括整合抽吸系统、用于更好密封的袖带和声门下抽吸等功能,所有这些都有助于更好的呼吸支援和管理。一些先进的气管切开插管提供客製化选项,以满足个别患者的独特需求。
此外,气道疾病的盛行率不断增加、临床试验的增加、对插管的认识不断提高以及具有先进功能的技术先进插管的开发是预计在预测期内推动市场的因素。
与插管相关的併发症和风险等因素,如感染、纵膈气肿、喉部或气管损伤、气管切开插管阻塞、意外拔管、气管软化、气管食道瘘、气管狭窄和出血、缺乏熟练的专业人员以及高昂的费用预计管材的数量将阻碍市场。
A tracheostomy is a surgical procedure involving making an incision in the neck to insert a tube into the trachea, which is known as a tracheostomy tube. A tracheostomy tube is an artificial airway that is surgically placed directly into the trachea through an opening in the throat. It bypasses the upper airway as a means to establish a connection for breathing. Tracheostomy tubes facilitate positive pressure ventilation, allow for access for secretion removal, and provide a patent airway for patients with obstructed upper airways.
A tracheostomy provides an air passage that helps to breathe when the usual route for breathing is somehow blocked or reduced. A tracheostomy tube is often needed when health problems require long-term use of a machine (ventilator) to help breathe. In rare cases, an emergency tracheotomy is performed when the airway is suddenly blocked, such as after a traumatic injury to the face or neck. When a tracheostomy is no longer needed, it's allowed to heal shut or is surgically closed. For some people, a tracheostomy is permanent.
The increasing advancements in tracheostomy tubes is expected to drive the market over the forecast period. The advancements in these tubes helps to provide a wide range of options for patients to choose according to the patients choice. Advanced tracheostomy tubes often come with designs that prioritize patient comfort. Features such as softer materials, reduced irritation, and ergonomic designs contribute to improved patient tolerance and compliance, leading to increased acceptance of tracheostomy tubes.
For instance, in January 2020, Smiths Medical, a global medical device manufacturer, has launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. When caring for a patient with a tracheostomy, a tube should be chosen to best suit the patient's specific clinical need. The new tracheostomy tubes have options for a variety of patients.
Moreover, technological innovations aim to address common complications associated with tracheostomy tubes, such as infections, granuloma formation, and tracheal stenosis. By minimizing these risks, advanced tracheostomy tubes enhance the safety profile of the procedure, encouraging patients to opt for this intervention when needed. The increasing airway disorders such as asthma are increasing the demand for tracheostomy tubes.
For instance, according to the CDC's 2020 National Health Interview Surveys (NHIS), an estimated 25.2 million adults, including 4.2 million children, have asthma in the United States. In 2020, more than 10.3 million asthmatics, including approximately 1.8 million children, reported having one or more asthma attacks. Therefore, orotracheal intubation is preferred for asthmatic patients in acute respiratory distress. Thus, from the above statements, the market is expected to drive market growth.
Additionally, advancements in materials and design led to tracheostomy tubes with improved functionality. This includes features like integrated suction systems, cuffs for better sealing, and subglottic suctioning, all of which contribute to better respiratory support and management. Some advanced tracheostomy tubes offer customization options to meet the unique needs of individual patients.
Further, the increasing prevalence of airway disorders, increasing clinical trials, increasing awareness about the tubes and development of technologically advanced tubes with advanced features are the factors expected to drive the market over the forecast period.
Factors such as complications and risks associated with the tubes such as infection, pneumomediastinum, damage to the larynx or trachea, obstruction in the tracheostomy tube, accidental decannulation, tracheomalacia, tracheoesophageal fistula, tracheal stenosis and bleeding, lack of skilled professionals and the high cost of the tubes are expected to hamper the market.
The global tracheostomy tube market is segmented based on type, component, material, end-user and region.
The polyvinyl chloride (PVC) tubes segment is expected to hold the largest market share over the forecast period. PVC softens at body temperature, conforming to patient anatomy and centering the tube in the trachea. PVC is generally considered biocompatible, meaning it is well-tolerated by the human body. This is a crucial characteristic of materials used in the tracheostomy tubes.
Moreover, PVC tubes are also known for their flexibility, which is essential for medical tubing applications. They can be easily shaped and molded to suit the specific requirements of tracheostomy tubes. PVC is also durable and resistant to breakage, which offers wide advantages for patients using tracheostomy tubes. PVC tubes are often transparent, allows to visually inspect fluids passing through the tube. This transparency is advantageous for monitoring and assessing the patient's condition.
Furthermore, PVC can be easily sterilized, making it suitable for maintaining sterility. PVC is a cost-effective material, which is an important consideration for tracheostomy tubes. PVC is resistant to many chemicals, which is beneficial for applications where the tube may come into contact with various fluids and medications. Thus, owing to the above factors, the segment is expected to largest market share.
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of tracheostomy tubes. North America especially the United States is home to many major players such as medical device companies manufacturing tracheostomy tubes. These companies often have well-established and extensive research and development capabilities and a strong market presence. The presence of major players actively performing in clinical trials, leads to the advancements in the tracheostomy tubes.
In addition, the region is also known for the increasing adoption of tracheostomy tubes for various airway applications. The aging population and the prevalence of respiratory conditions contribute to the growing adoption of tracheostomy tubes in the region. As the population ages, there is an increased likelihood of respiratory issues, necessitating interventions such as tracheostomy procedures by using tracheostomy tubes. The increasing adoption leads to the development of advanced tubes.
For instance, on June 21, 2023, Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, revealed a global recall of affected batches of the below-mentioned Rusch Endotracheal Tube products. The Rusch Endotracheal Tube devices are indicated for oral or nasal intubation for airway management via insertion into a patient's tracheal via nose or mouth. Stylets are used to aid the insertion of endotracheal tubes into the trachea.
The major global players in the tracheostomy tube market include: Teleflex Incorporated, Medtronic plc, Healthcare 21 Ltd, Advin Health Care, Gcmedica Enterprise Ltd., Global Medikit Limited, Angiplast Pvt Ltd., Coloplast Group, Boston Medical Products Inc. and TRACOE medical GmbH among others.
The COVID-19 pandemic significantly impacted the global tracheostomy tube market. COVID-19 primarily affects the respiratory system, and severe cases often require intensive respiratory support. This increased the demand for ventilators and other devices including tracheostomy tubes, to assist in the management of critically ill patients.
The pandemic created unprecedented challenges to the market by temporarily disrupting many clinical trials and research activities due to the redirected focus on the COVID-19 pandemic. The pandemic also disrupted the supply chain of devices globally.
The global tracheostomy tube market report would provide approximately 69 tables, 78 figures, and 189 Pages.
LIST NOT EXHAUSTIVE